SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-044915
Filing Date
2024-04-09
Accepted
2024-04-09 06:02:16
Documents
4
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm249796d1_def14a.htm DEF 14A 477062
2 GRAPHIC tm249796d1_pre14aimg001.jpg GRAPHIC 3658
3 GRAPHIC tm249796d1_pre14aimg002.jpg GRAPHIC 191297
4 GRAPHIC tm249796d1_pre14aimg003.jpg GRAPHIC 232275
  Complete submission text file 0001104659-24-044915.txt   1066723
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39231 | Film No.: 24831048
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)